560 New ASC Procedures in 2026: What It Means for Pre-Op & Anesthesia

A Scenario More ASCs Will Face This Year

Picture the scenario now playing out at facilities across the country. A cardiovascular group books a percutaneous coronary intervention at an ASC — something that, three months earlier, would have been unthinkable in an outpatient OR. The pre-op nurses stare at the H&P and don't know where to start. The anesthesia team hasn't credentialed for that case type. And the scheduler has simply dropped it into the block like it was a knee scope.

That scenario is why this rule change deserves more attention than it's getting. Over the past decade, the ASC environment has evolved from straightforward outpatient plastics and ortho to something that increasingly looks like a short-stay hospital. But what happened on January 1, 2026 is different. This isn't gradual creep. This is a regulatory earthquake, and a lot of facilities aren't ready for the aftershocks.

What CMS Actually Finalized — and Why It's Historic

On November 21, 2025, CMS released the CY2026 Outpatient Prospective Payment System and Ambulatory Surgical Center Final Rule. The headline number is 560 — as in, 560 surgical procedures added to the ASC Covered Procedures List (CPL) in a single rulemaking cycle, effective January 1, 2026. That's the largest single-year expansion in Medicare history. According to Holland & Knight's analysis of the final rule, 271 of those codes came directly off the Inpatient-Only (IPO) list — procedures that, until this year, Medicare required to be performed in a hospital inpatient setting.

Read that again: 271 procedures that previously mandated hospital admission are now payable in your ASC. We're not talking about moving tonsillectomies to a faster setting. We're talking about posterior lumbar interbody fusions, electrophysiology ablations, and percutaneous coronary interventions landing in outpatient ORs. Corazon Inc.'s 2025 breakdown of the expansion confirms those specific procedure categories are now ASC-eligible, along with complex orthopedic and reconstructive surgeries that used to default inpatient by sheer clinical convention.

And this isn't the end. CMS finalized a full three-year phaseout of the entire Inpatient-Only list, accelerated by one year from what was originally proposed, with full elimination completed by January 1, 2028. This is a structural, permanent shift — not a pilot, not a waiver program. If your ASC's pre-op and anesthesia workflows were built for the old case mix, you're already behind.

Five Exclusion Criteria Are Gone — Which Means the Judgment Is Now Yours

Here's the part of the rule that's underreported in most of the trade coverage: CMS didn't just add procedures. They eliminated five regulatory exclusion criteria that previously gave ASCs a kind of administrative backstop — rules that blocked certain higher-acuity cases from ASC coverage regardless of individual patient fitness. Those guardrails are gone. As Holland & Knight notes, CMS explicitly shifted those clinical judgments to physicians on a case-by-case basis.

From an anesthesia standpoint, that's both empowering and sobering. It means the conversation every perioperative team has had internally — is this patient right for an outpatient setting? — is now the only conversation that stands between a safe outcome and a catastrophic one. There's no regulatory filter catching cases that slip through a weak pre-op screen. The liability is clinical, not administrative.

What does "wrong patient, wrong setting" look like in practice? It looks like a 68-year-old with an EF of 35% booked for a posterior lumbar interbody fusion because the code is now on the CPL and someone assumed CMS approval equals clinical clearance. It looks like a patient on dual antiplatelet therapy scheduled for a percutaneous coronary intervention without a structured hematologic review. It looks like a BMI-45 patient scheduled for complex reconstructive surgery in a facility without ventilator protocols for prolonged cases. These aren't hypotheticals — they're the near-misses that happen when billing eligibility outruns clinical infrastructure.

The Anesthesia Staffing Crisis Is Real, and It Just Got Worse

One thing deserves to be said directly: anesthesia workforce capacity in the ASC space was already stretched before January 1, 2026. Now facilities are adding cardiovascular and complex spine cases to the mix, and the staffing math doesn't work without a fundamental rethink of how pre-op and intraoperative coordination happens.

ASC News's 2026 trend analysis identifies anesthesia as "one of the most acute pressure points" as higher-acuity cardiovascular, spine, and orthopedic cases migrate outpatient. The pressure is structural: higher-acuity cases take longer to evaluate, require more nuanced pre-op data review, and generate more anesthesia-to-surgeon communication that has to happen before the day of surgery — not in the holding area fifteen minutes before incision.

Consider what a complex cardiac case requiring MAC or GETA in an ASC setting actually involves: reviewing baseline ECG findings, current medications (are they on amiodarone? what's the sotalol dose?), functional capacity, and often a conversation with the patient's cardiologist. That review used to happen in a hospital pre-anesthesia clinic with nursing staff, coordinators, and an EMR built for it. In a private ASC, you're often doing that work with a fraction of the infrastructure. If you're doing 30 cases a week and even 20% of them are now higher-acuity, that review burden compounds fast.

The broader context matters too. Transcure's 2026 ASC billing guide puts the scale of the industry in perspective: over 6,300 Medicare-certified ASCs, approximately 3.4 million fee-for-service beneficiaries treated annually, and a market exceeding $50 billion with nearly 18,000 operating rooms nationwide. The infrastructure absorbing this case migration is massive — but it wasn't built for inpatient-complexity cases.

The Revenue Is Real — But So Is the Risk

For the private-practice surgeons and ASC administrators reading this, one thing should be said plainly: the financial incentive to embrace this expansion is significant. CMS finalized a 2.6% ASC payment rate increase for CY2026, bringing the ASC conversion factor to $56.322 — compared to $91.415 for hospital outpatient departments. That gap is the entire business case for ASC surgery, and it's why cases keep migrating. Becker's ASC Review's analysis outlines these payment dynamics and their effect on case migration in detail.

For private-practice plastic surgeons in particular, who are already running cash-pay cosmetic cases billing $12,000 to $25,000 per procedure, adding newly eligible reconstructive cases to the same ASC infrastructure is a natural extension — if the clinical protocols are in place. A complex reconstructive case that previously defaulted to hospital admission now generating an ASC-level facility fee, paired with a cash-pay aesthetic case the same morning, is exactly the kind of schedule optimization that well-run private ASCs are designed for.

But here's the math that doesn't show up in the revenue projections: a cancelled case the morning of surgery — because pre-op screening missed an uncontrolled INR, a newly started SGLT2 inhibitor nobody flagged, or a baseline creatinine that should have triggered cardiology clearance — costs you the facility fee, the anesthesia time, and the surgeon's blocked OR slot. On a $20,000 cash-pay case, that's a full day of revenue gone. The ROI of a rigorous pre-op screening system isn't just clinical — it's financial.

What Your Pre-Op Workflow Actually Needs Right Now

The CMS ASC expansion 2026 isn't just a billing update — it requires a clinical operations response in four specific areas:

• Procedure-specific screening criteria: A blanket pre-op checklist built for outpatient plastics and ortho is not sufficient for a posterior lumbar interbody fusion or a cardiac ablation. You need structured, procedure-linked screening that flags acuity-specific risks — think cardiac clearance thresholds, anticoagulation protocols, airway complexity scoring — before the case hits the schedule.
• Standardized anesthesia suitability review: The anesthesia team needs to be integrated into the pre-op screening workflow, not handed a chart the morning of surgery. For higher-acuity outpatient surgery, the anesthesia provider needs the patient's functional capacity, current beta-blocker regimen, and baseline glucose (especially for diabetics on metformin or SGLT2 inhibitors with their associated perioperative risks) days before the patient arrives.
• Clear ASC candidacy criteria: With the five exclusion criteria eliminated, your facility needs its own written patient-selection policy. What EF cutoff triggers a hospital referral? What BMI threshold requires an airway plan documented before booking? These decisions used to be partly outsourced to regulation. Now they're yours.
• Documentation that supports the clinical decision: Because CMS has shifted the judgment to the physician, your documentation needs to reflect that individualized assessment. A templated note that says "patient cleared for outpatient surgery" isn't going to hold up if there's a complication and someone asks how you determined this 71-year-old with three cardiac stents was an appropriate ASC candidate for a lumbar fusion.

This is exactly the workflow gap that VeriOp.ai was designed to address. The platform provides structured, AI-assisted pre-operative screening designed to support anesthesia and surgical teams in evaluating patient candidacy for specific procedures — including the higher-acuity case types now entering the ASC setting. It's designed to meet criteria for Clinical Decision Support under the 21st Century Cures Act, which matters when you're building defensible, documented clinical workflows in a rapidly shifting regulatory environment. If you want to see the outcomes data behind the platform, the validation study is available here.

Looking at 2028 — and Why You Can't Wait

January 1, 2028 is when CMS has committed to completing the full elimination of the Inpatient-Only list. That means whatever complex case types aren't yet landing in your ASC are likely coming. The facilities that will thrive in that environment are the ones building their clinical infrastructure now — patient selection protocols, anesthesia pre-op integration, procedure-specific screening, and documentation standards — not the ones retrofitting their workflows after a critical incident.

A consistent pattern shows up across facilities: the ASCs that handle high-acuity cases well aren't necessarily the ones with the most resources. They're the ones where the pre-op process is treated as a clinical function, not an administrative checkbox. They cancel fewer cases. They have fewer same-day delays. Their anesthesia teams show up to cases with complete information. And they have the documentation to defend every patient-selection decision they make.

The CMS ASC expansion of 2026 is the most significant structural change to outpatient surgery in a generation. The 560 new procedures on the ASC covered procedures list aren't a distant policy update — they're in your OR right now. The question isn't whether your facility will see these cases. It's whether your pre-op screening and anesthesia staffing workflows are ready when they arrive.

VeriOp.ai was built specifically for this moment — for the private-practice ASC that needs rigorous, scalable pre-op screening without the overhead of a hospital pre-anesthesia clinic. If your facility is booking higher-acuity outpatient surgery cases and your pre-op process hasn't kept pace, that's a patient safety problem and a financial risk. Let's fix it before the morning of surgery.